---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-018140"
form_type: "8-K"
ticker: "DMAC"
cik: "0001401040"
company_name: "DiaMedica Therapeutics Inc."
filed_at: "2024-05-23T23:59:59+00:00"
generated_at: "2026-06-01T09:08:01.766283+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# DiaMedica shareholders approve 3M share increase to 2019 Omnibus Incentive Plan

## Summary
- Shareholders approved amendment to increase shares available under 2019 Omnibus Incentive Plan by 3,000,000 shares.
- All seven director nominees elected with >13.5M votes each; broker non-votes of ~11.77M.
- Baker Tilly US, LLP appointed as independent auditor for FY2024 with 24.97M votes for.
- Advisory vote on executive compensation passed (13.18M for); shareholders prefer one-year say-on-pay frequency.
- 67.9% of outstanding shares (25.77M of 37.96M) voted at the annual meeting.

## SEC filing metadata
- accession: 0001437749-24-018140
- form_type: 8-K
- ticker: DMAC
- cik: 0001401040
- company_name: DiaMedica Therapeutics Inc.
- filed_at: 2024-05-23T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401040/000143774924018140/0001437749-24-018140-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401040/000143774924018140/dmtp20240523_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-018140
- JSON: https://secwatch.observer/filing/0001437749-24-018140.json
- Plain text: https://secwatch.observer/filing/0001437749-24-018140.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.